Washington, D.C. January 5, 2011. On Monday, the United States Court of Appeals for the Fourth Circuit ruled in favor of a sickle cell disease researcher who blew the whistle on improper cloning of blood cell lines. The decision clears the way Dr. Duane Bonds to proceed with her claim that the National Institutes of Health fired her in retaliation for blowing the whistle on the improper cloning of cell lines without consent.
This is the first case in which a federal employee will be allowed to
pursue a whistleblower lawsuit in federal district court. Dr. Bonds'
attorney is Michael Kohn, president of the National Whistleblowers
Center and a partner with Kohn, Kohn & Colapinto, LLP, in
Washington, DC. Kohn said: "This decision expands the rights of
some federal workers to pursue their whistleblower claims in federal
district courts around the country. Unfortunately, since Congress
continues to treat federal employees as second-class citizens this right
is only available to federal employees who are able to bring a race,
sex, age, national origin or religion claim in conjunction with a
whistleblower claim. Otherwise, a federal employee has no right to a
federal court hearing."
Dr. Bonds, a female African-American
medical officer, worked under National Institute of Health's National
Heart Lung and Blood Institute (NHLBI) since 1990. She was responsible
for coordinating and overseeing all of NHLBI's sickle cell disease human
clinical trials and epidemiologic studies. Sickle cell disease is the
most frequently inherited blood disorder in the United States, which in
this country afflicts primarily persons of Sub-Saharan African descent.
Dr.
Bonds learned that blood from African-American infants was taken from
participants enrolled in the clinical trial for which she was the
project officer without proper informed consent in order to create
immortalized cell lines for future scientific study. Dr. Bonds was
shocked when she learned of the unauthorized cloning and, as the project
officer ordered the immediate destruction of all of the improperly
created cell lines. Bonds' supervisor, Dr. Charles Peterson, interceded
and overruled Bonds' order. Dr. Bonds subsequently brought her
concerns to NHLBI's Director, Dr. Elizabeth Nabel, who initially agreed
with her, but ultimately failed to take steps to destroy the cell lines.
Retaliation
against Dr. Bonds was swift. Within days of raising the issue of the
illegally cloned cell lines with Dr. Nabel, a memorandum was handed to
Dr. Bonds which stated that she was under investigation and was being
summarily removed her from her role as the Sickle Cell Disease
Coordinator and was threatened with termination if she raised concerns
about the illegally cloned cell lines or discussed that she had been
removed from her position with anyone. NHLBI then paid an outside
attorney over $100,000 of taxpayer money to conduct the investigation
that led to her termination.
Frustrated by the corrupted
internal process, Dr. Bonds decided to report the existence of the
illegally cloned cell lines to the federal Office of Special Counsel
(OSC). The OSC
concluded that NHLBI's failure to destroy the cell lines violated
federal law and issued a report to the President to that effect. In the
midst of the OSC investigation, NHLBI illegally searched Dr. Bonds'
emails with her attorney and located a copy of the OSC complaint.
Bonds was terminated shortly after that when she was blamed for missing
expiration dates on drug labels used by outside investigators in one of
her studies. Dr. Bonds supervisor, Dr. Peterson, knew that the missing
labels had been reported a year earlier to others and ignored this fact
in order to blame Dr. Bonds.
The Fourth Circuit ruling means
that Dr. Bonds can proceed in a federal district court to prove that her
discharge was part of a witch-hunt that was mounted in response to her
whistleblowing. Attorney Kohn further stated: "The time has come for
NHLBI to answer for its decision to gag Dr. Bonds and terminate her for
exposing unethical treatment of study participants."
The
Court of Appeals decision reinstates Dr. Bonds' claims against NHLBI
under the Whistleblower Protection Act and the Civil Service Reform Act
(CSRA). However, it let stand the lower court's summary judgment against
Dr. Bonds on her claim of race discrimination.
Dr. Bonds
released the following statement: "I am grateful that the Court of
Appeals recognized the importance of allowing me to bring my
whistleblower case forward. I wish that Congress would provide a
new law granting all federal whistleblowers modern legal protections."
Links:
Fourth
Circuit Decision in Bonds v. Dept. of Health and Human Services
Letter
from Office of Special Counsel to President on findings in Bonds case
***
|